Skip to main content
UniHealth

Doctor search

Minal Bhanushali, MD

Neurology · Palo Alto

NPI 1265618995

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
12
3 carriers
Offices
11

Offices

11 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: 058123 · Mills-Peninsula Medical Center · Sutter Solano Medical Center. That is not proof they admit you there this week.

Plans that list them

12 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bhanushali’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

12 of 12 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Sutter Advantage +More (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A113308 · Current

Licensed to practise in California · since 2010 · expires 2028-03-31 · University of Mumbai, Grant Medical College.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
  • Sutter Solano Medical CenterVallejo, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 61% would definitely recommend it
    Overall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.272, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Peninsula Medical Center
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.139BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.242BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.21 (0.27 to 2.15) · 1,258 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.81 (0.51 to 1.1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths155.44 (112.67 to 198.21) · 90 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.5 · 32 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 82 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10 · 188 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9 · 473 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.8 · 342 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.4 · 485 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.9 · 3,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.2 (0 to 0.4) · 6,904 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.02 to 0.4) · 7,052 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.41 (1.43 to 5.39) · 1,695 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.72 (0.17 to 3.28) · 665 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.66 to 3.56) · 1,545 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.1 (1.3 to 12.9) · 670 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.96 (2.63 to 9.29) · 653 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.15 to 3.08) · 418 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.14 (0 to 0.78) · 5,539 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.7 · 192 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.215No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.263No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.74No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.3 · 300 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19 · 702 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits1.2 · 207 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-13.6 · 531 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits24.3 · 343 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.1 · 449 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits4.5 (2.8 to 7) · 85 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits9.6 (6.7 to 13.7) · 85 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.7 · 189 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits11 · 45 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.6 · 117 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13 (9.7 to 17.2) · 584 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.2) · 764 casesNo differentJan 2024 – Dec 2024

What patients said (523 patients answered, 27% of those asked)

Patient survey stars by topic at Peninsula Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at Peninsula Medical Center
Room was "always" clean76%
Nurses "always" communicated well81%
Doctors "always" communicated well80%
Staff "always" explained58%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully79%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)75%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night54%
"YES", patients would definitely recommend the hospital78%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Sutter Solano Medical Center

Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Sutter Solano Medical Center
Clostridium Difficile (C.Diff)Infections0.272BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.93 (0 to 1.95) · 374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.99 (0.6 to 1.38)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths162.36 (106.6 to 218.11) · 31 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths7.3 · 77 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.9 · 28 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths11.2 · 113 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths16.2 · 154 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.3 · 65 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.6 · 960 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.19 (0 to 0.41) · 2,268 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.25 (0.04 to 0.46) · 2,327 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.7 (0.38 to 5.03) · 594 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.61 (0 to 3.31) · 285 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.13 (0.47 to 3.78) · 581 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.1 (0 to 16.32) · 302 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.77 (3.74 to 11.8) · 275 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.72 (0.21 to 3.24) · 114 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.59 (0 to 1.48) · 1,998 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths5.8 · 171 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.4 · 142 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits0.8 · 131 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits33 · 162 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18 · 160 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.5 (3.6 to 8.5) · 42 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10 (6.8 to 14.4) · 42 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.7 · 165 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 76 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits14.2 (10.6 to 18.9) · 322 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.8 to 1.6) · 84 casesNo differentJan 2024 – Dec 2024

What patients said (355 patients answered, 17% of those asked)

Patient survey stars by topic at Sutter Solano Medical Center
Cleanliness2
Nurse communication3
Doctor communication3
Communication about medicines2
Discharge information3
Overall hospital rating2
Quietness1
Recommend hospital3
Share of patients giving the best answer at Sutter Solano Medical Center
Room was "always" clean63%
Nurses "always" communicated well77%
Doctors "always" communicated well78%
Staff "always" explained57%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge84%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully76%
Doctors "always" treated them with courtesy and respect84%
Patients who gave a rating of "9" or "10" (high)64%
Staff "always" explained new medications69%
Nurses "always" explained things so they could understand72%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night43%
"YES", patients would definitely recommend the hospital61%
Staff "always" explained possible side effects45%
Yes, staff "did" give patients information about possible symptoms86%

Original Medicare doctor bills

$181,490

Medicare paid this office $181,490 for 547 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)212$52,369$154
Botox23$50,507None
New patient visit (60+ min)107$20,174$189
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face15$5,202$137
Muscle electrical test49$4,813$98
See all 16 services
Every Original Medicare service billed
Long return visit (40+ min)212$52,369$154
Botox23$50,507None
New patient visit (60+ min)107$20,174$189
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face15$5,202$137
Muscle electrical test49$4,813$98
Nerve test26$4,475$172
Nerve test31$4,147$134
Muscle electrical test37$2,667$65
Return visit (30+ min)21$2,600$118
Nerve test20$2,227$111
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes57$1,744$31
Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth22$1,599$73
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's86$1,431$14
Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth11$1,272$116
Telephone or internet assessment with verbal and written report by consulting physician, 11-20 minutes45$1,237$27
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or17$469$26

Procedures Medicare counted

Procedure volume Medicare published
Skin biopsy1-10None

Who their Medicare patients are

547 Original Medicare patients in 2024. Average age 76 · Under 65 6% · 85 and older 18% · Women 58% · Also on Medicaid 12% · Health risk score 1.29. At or below the middle of the specialty; the typical neurology clinician is at 1.61.

Conditions among them: High blood pressure 71% · Stroke 29% · Coronary heart disease 26% · Depression 25% · Diabetes 24% · Chronic kidney disease 21% · Atrial fibrillation 18% · Dementia 18% · Cancer 16% · Heart failure 14% · COPD 12%.

The office billed $632,607, Medicare allowed $240,489 and paid $181,490; for 12,875 services of 51 kinds; $56,295 of it was for drugs given in the office and $125,196 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202454712,875761.29$632,607$181,490
20234508,711771.23$509,940$155,985
20224024,585781.04$433,108$138,870
20213753,227771.21$347,936$116,861
20203571,583771.14$265,935$83,510
20194292,471771.06$360,886$107,336
20184145,853761.13$430,106$131,738
20173603,583761.12$326,463$98,379
20163161,107741.21$208,689$66,558
20153231,110751.54$184,290$59,408
20144976731.74$15,555$4,996
20131825721.64$6,545$1,860

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 17 services

Original Medicare services billed in 2023
Long return visit (40+ min)237$57,281$156
Botox20$37,508None
New patient visit (60+ min)98$18,659$190
Measurement of brain wave activity (eeg), awake and drowsy15$6,646$415
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face11$3,052$133
New patient visit (45+ min)20$2,884$144
Return visit (30+ min)24$2,789$112
Muscle electrical test26$2,332$90
Nerve test19$2,305$121
Nerve test12$2,078$173
Muscle electrical test21$1,622$65
Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth14$1,112$79
Telephone medical discussion with physician, 11-20 minutes11$999$77
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes25$798$32
Short return visit (20+ min)11$796$72
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or26$771$28
Telephone or internet assessment with verbal and written report by consulting physician, 11-20 minutes15$411$27

2022: 11 services

Original Medicare services billed in 2022
Long return visit (40+ min)231$61,124$155
New patient visit (60+ min)106$20,737$196
Botox12$18,130None
Measurement of brain wave activity (eeg), awake and drowsy27$11,287$418
Return visit (30+ min)49$5,274$103
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or36$1,437$30
Muscle electrical test11$1,138$103
Short return visit (20+ min)11$1,048$87
Telephone medical discussion with physician, 11-20 minutes12$988$71
Muscle electrical test11$818$68
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes22$718$33

2021: 11 services

Original Medicare services billed in 2021
Long return visit (40+ min)193$48,090$161
New patient visit (60+ min)87$16,505$190
Return visit (30+ min)80$10,264$112
Measurement of brain wave activity (eeg), awake and drowsy15$6,321$421
New patient visit (45+ min)21$3,342$159
Nerve test13$1,905$147
Muscle electrical test13$1,354$71
Short return visit (20+ min)15$1,245$83
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or23$892$31
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes22$725$33
Telephone, internet, or electronic health record assessment and management with verbal and written report by consulting physician, 5-10 minutes11$185$17

2020: 13 services

Original Medicare services billed in 2020
Long return visit (40+ min)109$18,213$128
New patient visit (60+ min)85$15,151$178
Return visit (30+ min)99$10,880$91
Measurement of brain wave activity (eeg), awake and drowsy12$4,809$401
New patient visit (45+ min)23$3,351$146
Telephone medical discussion with physician, 21-30 minutes23$2,627$105
Short return visit (20+ min)33$2,288$64
Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth12$2,228$186
Nerve test11$2,120$193
Muscle electrical test25$1,918$66
Nerve test12$1,646$137
Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth16$1,470$92
Telephone medical discussion with physician, 11-20 minutes17$1,397$74

2019: 11 services

Original Medicare services billed in 2019
Return visit (30+ min)179$23,622$94
New patient visit (60+ min)131$23,558$180
Long return visit (40+ min)98$14,317$128
Measurement of brain wave activity (eeg), awake and drowsy19$7,128$375
Measurement of brain wave activity (eeg), awake and asleep11$4,611$419
New patient visit (45+ min)29$3,611$125
Short return visit (20+ min)51$3,462$65
Nerve test21$2,794$133
Nerve test14$2,434$174
Muscle electrical test25$2,360$94
Muscle electrical test21$1,533$64

2018: 13 services

Original Medicare services billed in 2018
New patient visit (60+ min)129$23,180$180
Botox14$22,974None
Return visit (30+ min)161$22,225$93
Long return visit (40+ min)83$11,774$127
Measurement of brain wave activity (eeg), awake and drowsy28$10,753$384
Measurement of brain wave activity (eeg), awake and asleep16$7,168$448
New patient visit (45+ min)48$6,926$144
Short return visit (20+ min)53$3,791$64
Nerve test22$3,232$147
Nerve test12$2,352$196
Muscle electrical test24$2,187$91
Muscle electrical test28$2,126$61
New patient visit (30+ min)17$1,423$84

2017: 11 services

Original Medicare services billed in 2017
Return visit (30+ min)135$18,386$97
New patient visit (60+ min)74$13,739$186
Long return visit (40+ min)71$10,701$129
New patient visit (45+ min)67$9,841$147
Short return visit (20+ min)72$5,812$65
Nerve test22$3,241$147
New patient visit (30+ min)31$3,032$98
Nerve test16$2,973$186
Muscle electrical test27$2,625$87
Muscle electrical test27$1,840$59
Nerve test11$1,463$122

2016: 15 services

Original Medicare services billed in 2016
New patient visit (45+ min)58$8,662$149
Return visit (30+ min)57$7,142$101
New patient visit (30+ min)64$6,196$97
Measurement of brain wave activity (eeg), awake and drowsy13$4,901$377
Critical care, first 30-74 minutes23$4,341$167
Long return visit (40+ min)28$3,563$119
Short return visit (20+ min)41$3,247$66
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes21$3,140$79
Initial hospital care with moderate level of medical decision making at least 75 minutes20$3,107$155
Nerve test17$2,405$141
New patient visit (60+ min)12$2,278$190
Nerve test11$2,048$186
Muscle electrical test17$1,537$90
Muscle electrical test18$1,198$60
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes12$909$50

2015: 11 services

Original Medicare services billed in 2015
Critical care, first 30-74 minutes48$12,702$169
Initial hospital care with moderate level of medical decision making at least 75 minutes57$8,587$151
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes35$3,717$106
New patient visit (45+ min)23$3,653$159
New patient visit (30+ min)26$2,733$105
Return visit (30+ min)25$2,672$99
Short return visit (20+ min)29$2,506$72
Critical care, each additional 30 minutes17$1,896$86
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes30$1,891$54
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes16$1,862$81
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes24$908$30

2014: 3 services

Original Medicare services billed in 2014
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes19$1,511$80
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes15$1,220$58
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes11$580$31

Drugs they prescribed that Part D paid

$242,344

Pharmacies billed $242,344 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 3% of their Part D prescriptions (42 of 1,692) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%. Long-acting opioids: 38% of their opioid prescriptions.

1,535 generic and fewer than 11 brand-name prescriptions · $242,344 in drug cost · 81 antipsychotic prescriptions to people over 65.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
RytaryParkinson's19$32,115$1,690
NourianzNone12$23,305$1,942
EmgalityMigraine23$23,050$1,002
UbrelvyNone14$13,589$971
Nurtec OdtNone12$13,565$1,130
See all 38 drugs
Every Part D drug this clinician prescribed
RytaryParkinson's19$32,115$1,690
NourianzNone12$23,305$1,942
EmgalityMigraine23$23,050$1,002
UbrelvyNone14$13,589$971
Nurtec OdtNone12$13,565$1,130
AimovigMigraine13$10,738$826
EmgalityMigraine13$8,748$673
Carbidopa-LevodopaNone123$6,344$52
GabapentinNone224$4,973$22
Carbidopa-Levodopa ErNone58$3,504$60
LevetiracetamNone46$3,172$69
Lamotrigine ErNone23$2,381$104
MemantineNone52$1,910$37
DonepezilNone128$1,571$12
QuetiapineNone80$1,524$19
RivastigmineNone23$1,466$64
PregabalinNone65$1,344$21
PrimidoneNone24$1,003$42
Divalproex Sodium ErNone21$921$44
PropranololNone61$846$14
DivalproexNone18$844$47
Bupropion XlNone19$776$41
BaclofenNone38$764$20
TrazodoneNone58$727$13
DuloxetineNone26$677$26
Fludrocortisone AcetateNone14$656$47
RizatriptanNone15$580$39
EscitalopramNone43$573$13
ClopidogrelNone18$371$21
TopiramateNone12$255$21
DiazepamNone14$248$18
MirtazapineNone11$230$21
MeloxicamNone16$176$11
AtorvastatinNone20$165$8
MethadoneNone16$139$9
NortriptylineNone13$131$10
LorazepamNone25$117$5
TramadolNone18$49$3

Year by year

Part D prescribing by year
20241,6923263% (42)None$242,344
20231,5783272% (31)None$262,970
20221,6152971% (22)None$348,135
20211,3942792% (24)None$178,386
20201,1982562% (27)6%$140,373
20191,1032454% (41)None$160,934
20181,2152372% (28)15%$235,538
20171,0372061% (15)None$117,235
20164871403% (13)None$64,904
2015309108None7%$22,300
20144541557% (32)23%$65,711
20133971438% (31)37%$104,813

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 32 drugs

Part D drugs prescribed in 2023
RytaryParkinson's15$39,316$2,621
EmgalityMigraine28$28,153$1,005
AimovigMigraine14$10,642$760
Carbidopa-LevodopaNone101$5,721$57
GabapentinNone181$5,173$29
Lamotrigine ErNone15$5,118$341
MemantineNone62$3,680$59
RivastigmineNone36$3,666$102
PregabalinNone52$3,315$64
Carbidopa-Levodopa ErNone51$3,251$64
DonepezilNone149$2,819$19
QuetiapineNone48$2,197$46
DivalproexNone31$2,168$70
LevetiracetamNone36$2,108$59
DuloxetineNone37$1,925$52
Fludrocortisone AcetateNone21$1,279$61
PrimidoneNone24$1,234$51
EscitalopramNone64$1,088$17
BaclofenNone13$1,009$78
RopiniroleNone14$1,000$71
PropranololNone50$983$20
RizatriptanNone26$928$36
TrazodoneNone37$603$16
LamotrigineNone27$411$15
LorazepamNone45$304$7
ClopidogrelNone19$280$15
MirtazapineNone11$218$20
CyclobenzaprineNone23$145$6
DiazepamNone16$143$9
AtorvastatinNone13$139$11
MethadoneNone15$122$8
MethocarbamolNone17$10$1

2022: 43 drugs

Part D drugs prescribed in 2022
EmgalityMigraine19$22,666$1,193
RytaryParkinson's22$18,998$864
EliquisNone11$14,655$1,332
AimovigMigraine17$13,099$771
LacosamideNone14$7,238$517
Lamotrigine ErNone15$6,838$456
Carbidopa-LevodopaNone77$6,570$85
GabapentinNone194$5,545$29
Carbidopa-Levodopa ErNone37$3,632$98
RivastigmineNone40$3,558$89
SumatriptanNone17$3,165$186
PregabalinNone42$2,753$66
DonepezilNone151$2,656$18
Divalproex Sodium ErNone16$2,473$155
Mycophenolate MofetilNone17$1,811$107
DuloxetineNone39$1,573$40
QuetiapineNone65$1,523$23
DivalproexNone23$1,516$66
EscitalopramNone74$1,498$20
PrednisoneNone14$1,467$105
MemantineNone28$1,399$50
OxcarbazepineNone11$1,381$126
RopiniroleNone27$1,377$51
PrimidoneNone17$914$54
RizatriptanNone28$714$26
PropranololNone40$697$17
Fludrocortisone AcetateNone19$687$36
MirtazapineNone15$630$42
TrazodoneNone33$620$19
LevetiracetamNone22$576$26
NortriptylineNone15$571$38
ClopidogrelNone33$555$17
Pramipexole DihydrochlorideNone18$478$27
BaclofenNone12$468$39
AtorvastatinNone42$364$9
LamotrigineNone15$364$24
LorazepamNone34$267$8
CyclobenzaprineNone17$267$16
Oxybutynin Chloride ErNone11$266$24
Potassium ChlorideNone12$138$12
TopiramateNone17$129$8
TramadolNone13$65$5
MethocarbamolNone12$19$2

2021: 36 drugs

Part D drugs prescribed in 2021
RytaryParkinson's31$33,830$1,091
VimpatNone15$28,127$1,875
EmgalityMigraine13$19,283$1,483
Carbidopa-LevodopaNone89$9,050$102
PregabalinNone64$4,822$75
GabapentinNone168$3,470$21
MirtazapineNone15$2,471$165
DonepezilNone113$2,469$22
RivastigmineNone26$2,340$90
MemantineNone32$1,612$50
Carbidopa-Levodopa ErNone19$1,319$69
DuloxetineNone40$1,316$33
QuetiapineNone51$1,045$20
EscitalopramNone55$1,030$19
PropranololNone37$954$26
LevetiracetamNone11$891$81
DivalproexNone16$878$55
Fludrocortisone AcetateNone13$810$62
RopiniroleNone26$735$28
ClopidogrelNone40$685$17
AmitriptylineNone11$653$59
RizatriptanNone30$629$21
NortriptylineNone29$625$22
TrazodoneNone27$580$21
AtorvastatinNone37$573$15
FamotidineNone14$453$32
Pramipexole DihydrochlorideNone16$413$26
LamotrigineNone12$373$31
ClonazepamNone19$368$19
PrimidoneNone16$348$22
Oxybutynin Chloride ErNone13$345$27
PrednisoneNone26$316$12
TopiramateNone18$163$9
CyclobenzaprineNone13$160$12
LorazepamNone30$148$5
TramadolNone14$30$2

2020: 33 drugs

Part D drugs prescribed in 2020
EmgalityMigraine12$11,721$977
RytaryParkinson's17$9,610$565
NucyntaNone12$7,900$658
Carbidopa-LevodopaNone82$6,529$80
PregabalinNone63$6,298$100
MirtazapineNone27$3,721$138
GabapentinNone100$2,417$24
Carbidopa-Levodopa ErNone26$1,800$69
DonepezilNone85$1,321$16
PropranololNone31$1,286$41
MemantineNone19$1,148$60
QuetiapineNone60$1,084$18
RivastigmineNone17$1,072$63
AmitriptylineNone15$1,003$67
LevetiracetamNone21$906$43
DuloxetineNone26$873$34
TrazodoneNone42$759$18
Fludrocortisone AcetateNone14$689$49
EscitalopramNone37$655$18
ClopidogrelNone37$652$18
AtorvastatinNone36$611$17
Oxybutynin Chloride ErNone13$536$41
LamotrigineNone17$527$31
NortriptylineNone23$437$19
Pramipexole DihydrochlorideNone15$391$26
RizatriptanNone16$386$24
TopiramateNone14$336$24
RopiniroleNone17$312$18
PrednisoneNone15$255$17
PrimidoneNone12$250$21
ClonazepamNone12$185$15
LorazepamNone33$107$3
TramadolNone12$21$2

2019: 32 drugs

Part D drugs prescribed in 2019
LyricaNone32$30,410$950
NucyntaNone12$5,648$471
RytaryParkinson's16$5,595$350
Carbidopa-LevodopaNone76$4,736$62
GabapentinNone121$3,886$32
PregabalinNone15$3,245$216
MirtazapineNone40$2,727$68
Carbidopa-Levodopa ErNone35$2,346$67
MemantineNone21$1,413$67
DonepezilNone60$1,231$21
AtorvastatinNone40$1,020$26
DuloxetineNone28$1,007$36
QuetiapineNone52$748$14
PropranololNone32$743$23
LevetiracetamNone26$727$28
AmitriptylineNone13$706$54
DivalproexNone16$685$43
Oxybutynin Chloride ErNone14$649$46
ClopidogrelNone38$626$16
BaclofenNone11$501$46
EscitalopramNone24$419$17
OxcarbazepineNone15$410$27
TizanidineNone24$388$16
NortriptylineNone11$257$23
ClonazepamNone11$243$22
TrazodoneNone12$221$18
Pramipexole DihydrochlorideNone11$217$20
LorazepamNone14$201$14
PrednisoneNone16$191$12
TopiramateNone11$183$17
TramadolNone17$75$4
DiazepamNone12$43$4

2018: 31 drugs

Part D drugs prescribed in 2018
Lyrica83$58,570$706
Aptiom12$32,080$2,673
Neupro16$20,828$1,302
Carbidopa-Levodopa Er47$4,133$88
Carbidopa-Levodopa73$3,680$50
Gabapentin116$2,928$25
Duloxetine33$2,199$67
Mirtazapine42$1,775$42
Memantine16$1,419$89
Divalproex26$947$36
Mycophenolate Mofetil11$803$73
Donepezil51$728$14
Levetiracetam20$651$33
Amitriptyline22$637$29
Quetiapine35$616$18
Atorvastatin25$537$21
Trazodone30$520$17
Clopidogrel27$518$19
Nortriptyline28$476$17
Primidone19$446$23
Propranolol25$436$17
Baclofen18$375$21
Buspirone11$330$30
Oxcarbazepine12$310$26
Escitalopram25$280$11
Clonazepam13$172$13
Lorazepam32$169$5
Zonisamide12$152$13
Prednisone12$151$13
Cyclobenzaprine11$137$12
Diazepam18$53$3

2017: 24 drugs

Part D drugs prescribed in 2017
Lyrica75$39,674$529
Carbidopa-Levodopa Er53$3,268$62
Duloxetine40$2,919$73
Sumatriptan11$2,887$262
Sumatriptan15$2,017$134
Memantine17$1,636$96
Carbidopa-Levodopa38$1,536$40
Gabapentin88$1,503$17
Levetiracetam32$834$26
Nortriptyline50$830$17
Donepezil66$790$12
Divalproex25$691$28
Quetiapine28$590$21
Bupropion Hcl Sr32$543$17
Atorvastatin31$472$15
Escitalopram46$471$10
Amitriptyline16$396$25
Clopidogrel23$274$12
Trazodone29$197$7
Baclofen12$193$16
Mirtazapine11$184$17
Topiramate16$169$11
Prednisone11$96$9
Lorazepam15$78$5

2016: 14 drugs

Part D drugs prescribed in 2016
Tegretol Xr12$2,286$190
Duloxetine15$1,866$124
Gabapentin75$1,472$20
Carbidopa-Levodopa Er16$810$51
Carbidopa-Levodopa23$683$30
Donepezil26$328$13
Nortriptyline13$324$25
Atorvastatin17$317$19
Escitalopram17$206$12
Fluoxetine11$201$18
Topiramate11$160$15
Oxcarbazepine11$151$14
Lorazepam14$102$7
Prednisone11$76$7

2015: 5 drugs

Part D drugs prescribed in 2015
Gabapentin72$3,544$49
Carbidopa-Levodopa Er25$2,697$108
Tegretol Xr12$2,131$178
Carbidopa-Levodopa27$1,156$43
Donepezil17$444$26

2014: 11 drugs

Part D drugs prescribed in 2014
Namenda25$23,181$927
Gabapentin89$5,361$60
Carbidopa-Levodopa Er27$2,818$104
Phenytoin Sodium Extended11$565$51
Nortriptyline26$334$13
Hydrocodone-Acetaminophen13$314$24
Prednisone11$269$24
Lorazepam25$213$9
Hydromorphone11$198$18
Diazepam18$182$10
Amitriptyline11$146$13

2013: 11 drugs

Part D drugs prescribed in 2013
Namenda16$11,146$697
Sumatriptan19$10,972$577
Lyrica12$4,331$361
Gabapentin69$3,251$47
Carbidopa-Levodopa15$1,120$75
Carbidopa-Levodopa Er13$843$65
Lorazepam22$232$11
Hydrocodone-Acetaminophen14$207$15
Amitriptyline16$186$12
Diazepam16$156$10
Nortriptyline11$127$12

Money from drug and device companies

$19,931 in 2025

Industry payments by year
2025420$17,350$19,931
2024226$16,025$17,663
202334None$134
202222None$107
20211217$1,695$2,019
2020912$1,130$1,409
20191028None$698

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Lilly USAKisunla$12,436
6 payments
  • Consulting for Kisunla · 2025-06-16 · $9,375
  • Consulting for Kisunla · 2025-06-16 · $2,200
  • Travel · 2025-06-06 · $177
  • Meals for Kisunla · 2025-06-06 · $176
  • Travel · 2025-06-06 · $191
  • Meals for Kisunla · 2025-06-06 · $317
EisaiLeqembi$7,441
12 payments
  • Consulting for Leqembi · 2025-12-03 · $825
  • Travel for Leqembi · 2025-07-23 · $558
  • Travel for Leqembi · 2025-07-19 · $310
  • Paid to speak or teach for Leqembi · 2025-07-17 · $3,300
  • Travel for Leqembi · 2025-07-17 · $124
  • Paid to speak or teach for Leqembi · 2025-07-17 · $1,375
  • Meals for Leqembi · 2025-07-17 · $120
  • Travel for Leqembi · 2025-06-05 · $343
  • Consulting for Leqembi · 2025-05-09 · $275
  • Meals · 2025-04-06 · $66
  • Meals · 2025-04-05 · $28
  • Meals for Leqembi · 2025-02-20 · $118
Eli Lilly andEmgality$29
1 payment
  • Meals for Emgality · 2025-04-06 · $29
AbbvieVyalev$26
1 payment
  • Meals for Vyalev · 2025-09-11 · $26
See all 20 published payments
Every published payment
EisaiConsulting · 2025-12-03Leqembi$825
AbbvieMeals · 2025-09-11Vyalev$26
EisaiTravel · 2025-07-23Leqembi$558
EisaiTravel · 2025-07-19Leqembi$310
EisaiPaid to speak or teach · 2025-07-17Leqembi$3,300
EisaiTravel · 2025-07-17Leqembi$124
EisaiPaid to speak or teach · 2025-07-17Leqembi$1,375
EisaiMeals · 2025-07-17Leqembi$120
Lilly USAConsulting · 2025-06-16Kisunla$9,375
Lilly USAConsulting · 2025-06-16Kisunla$2,200
Lilly USATravel · 2025-06-06None$177
Lilly USAMeals · 2025-06-06Kisunla$176
Lilly USATravel · 2025-06-06None$191
Lilly USAMeals · 2025-06-06Kisunla$317
EisaiTravel · 2025-06-05Leqembi$343
EisaiConsulting · 2025-05-09Leqembi$275
Eli Lilly andMeals · 2025-04-06Emgality$29
EisaiMeals · 2025-04-06None$66
EisaiMeals · 2025-04-05None$28
EisaiMeals · 2025-02-20Leqembi$118
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $17,663

Payments by company in 2024
EisaiLeqembi$17,585
25 payments
  • Paid to speak or teach for Leqembi · 2024-10-29 · $1,650
  • Paid to speak or teach for Leqembi · 2024-10-29 · $1,375
  • Meals for Leqembi · 2024-10-29 · $119
  • Meals for Leqembi · 2024-07-24 · $125
  • Paid to speak or teach for Leqembi · 2024-07-24 · $1,375
  • Paid to speak or teach for Leqembi · 2024-07-24 · $550
  • Consulting for Leqembi · 2024-06-13 · $1,650
  • Paid to speak or teach for Leqembi · 2024-06-12 · $550
  • Meals for Leqembi · 2024-06-12 · $124
  • Paid to speak or teach for Leqembi · 2024-06-12 · $1,375
  • Meals · 2024-05-15 · $82
  • Travel for Leqembi · 2024-05-07 · $8
  • Consulting for Leqembi · 2024-05-07 · $7,500
  • Meals for Leqembi · 2024-05-07 · $12
  • Travel for Leqembi · 2024-05-07 · $57
  • Travel for Leqembi · 2024-05-07 · $58
  • Meals for Leqembi · 2024-04-20 · $30
  • Meals for Leqembi · 2024-04-20 · $50
  • Meals for Leqembi · 2024-04-20 · $25
  • Meals for Leqembi · 2024-04-20 · $50
  • Meals for Leqembi · 2024-04-20 · $25
  • Meals for Leqembi · 2024-04-19 · $100
  • Travel for Leqembi · 2024-04-19 · $300
  • Travel for Leqembi · 2024-04-19 · $362
  • Meals for Leqembi · 2024-04-19 · $34
Lilly USAAmyvid$78
1 payment
  • Meals for Amyvid · 2024-01-10 · $78

2023: $134

Payments by company in 2023
Argenx USVyvgart$77
1 payment
  • Meals for Vyvgart · 2023-08-16 · $77
AbbVieQulipta$35
2 payments
  • Meals for Qulipta · 2023-11-07 · $17
  • Meals for Qulipta · 2023-01-03 · $18
Alexion PharmaceuticalsSoliris$22
1 payment
  • Meals for Soliris · 2023-02-24 · $22

2022: $107

Payments by company in 2022
BiogenVumerity$74
1 payment
  • Meals for Vumerity · 2022-03-18 · $74
Alexion PharmaceuticalsSoliris$33
1 payment
  • Meals for Soliris · 2022-03-19 · $33

2021: $2,019

Payments by company in 2021
BiogenTysabri$1,737
3 payments
  • Meals for Tysabri · 2021-08-24 · $25
  • Meals for Tysabri · 2021-05-26 · $17
  • Paid to speak or teach · 2021-03-26 · $1,695
Teva Pharmaceuticals USAAjovy$80
3 payments
  • Meals for Ajovy · 2021-11-08 · $23
  • Meals for Ajovy · 2021-09-13 · $32
  • Meals for Ajovy · 2021-06-12 · $25
Kyowa KirinNourianz$40
2 payments
  • Meals for Nourianz · 2021-02-03 · $21
  • Meals for Nourianz · 2021-01-08 · $18
Lilly USAEmgality$23
1 payment
  • Meals for Emgality · 2021-04-28 · $23
ACADIA PharmaceuticalsNuplazid$21
1 payment
  • Meals for Nuplazid · 2021-09-24 · $21
Novartis PharmaceuticalsKesimpta$21
1 payment
  • Meals for Kesimpta · 2021-05-17 · $21
Merz PharmaceuticalsXeomin$20
1 payment
  • Meals for Xeomin · 2021-04-05 · $20
Alexion PharmaceuticalsSoliris$19
1 payment
  • Meals for Soliris · 2021-08-16 · $19
Biohaven PharmaceuticalsNurtec Odt$19
1 payment
  • Meals for Nurtec Odt · 2021-05-24 · $19
UcbBriviact$15
1 payment
  • Meals for Briviact · 2021-02-01 · $15
CSL BehringHizentra$13
1 payment
  • Meals for Hizentra · 2021-09-20 · $13
Sunovion PharmaceuticalsKynmobi$11
1 payment
  • Meals for Kynmobi · 2021-05-07 · $11

2020: $1,409

Payments by company in 2020
BiogenNone$1,130
1 payment
  • Consulting · 2020-12-03 · $1,130
Alexion PharmaceuticalsSoliris$149
4 payments
  • Meals for Soliris · 2020-09-16 · $15
  • Meals for Soliris · 2020-07-06 · $15
  • Meals for Soliris · 2020-07-06 · $1
  • Meals for Soliris · 2020-02-13 · $118
UcbBriviact$29
1 payment
  • Meals for Briviact · 2020-06-16 · $29
AllerganUbrelvy$25
1 payment
  • Meals for Ubrelvy · 2020-03-09 · $25
ACADIA PharmaceuticalsNuplazid$18
1 payment
  • Meals for Nuplazid · 2020-01-22 · $18
Kyowa KirinNourianz$16
1 payment
  • Meals for Nourianz · 2020-03-06 · $16
EMD SeronoMavenclad$15
1 payment
  • Meals for Mavenclad · 2020-03-23 · $15
Supernus PharmaceuticalsTrokendi Xr$15
1 payment
  • Meals for Trokendi Xr · 2020-06-26 · $15
Sunovion PharmaceuticalsAptiom$12
1 payment
  • Meals for Aptiom · 2020-05-08 · $12

2019: $698

Payments by company in 2019
Alexion PharmaceuticalsSoliris$167
2 payments
  • Meals for Soliris · 2019-08-27 · $120
  • Meals for Soliris · 2019-02-22 · $46
EMD SeronoMavenclad$145
9 payments
  • Meals for Mavenclad · 2019-12-09 · $27
  • Meals for Mavenclad · 2019-10-02 · $13
  • Meals for Mavenclad · 2019-06-28 · $35
  • Meals for Mavenclad · 2019-06-21 · $5
  • Meals for Mavenclad · 2019-06-21 · $1
  • Meals for Mavenclad · 2019-06-16 · $23
  • Meals for Mavenclad · 2019-05-06 · $31
  • Meals for Mavenclad · 2019-04-26 · $6
  • Meals for Mavenclad · 2019-04-26 · $4
AmgenAimovig$127
2 payments
  • Meals for Aimovig · 2019-03-22 · $101
  • Meals for Aimovig · 2019-03-13 · $26
UcbBriviact$117
4 payments
  • Meals for Neupro · 2019-04-10 · $30
  • Meals for Briviact · 2019-02-14 · $50
  • Meals for Briviact · 2019-02-13 · $33
  • Meals for Briviact · 2019-02-13 · $3
Sunovion PharmaceuticalsAptiom$41
5 payments
  • Meals for Aptiom · 2019-10-16 · $5
  • Meals for Aptiom · 2019-09-23 · $3
  • Meals for Aptiom · 2019-08-16 · $18
  • Meals for Aptiom · 2019-07-24 · $10
  • Meals for Aptiom · 2019-04-12 · $5
PfizerLyrica$28
2 payments
  • Meals for Lyrica · 2019-07-03 · $12
  • Meals for Lyrica · 2019-02-11 · $16
Merz North AmericaXeomin$28
1 payment
  • Meals for Xeomin · 2019-08-08 · $28
AllerganBotox$19
1 payment
  • Meals for Botox · 2019-09-16 · $19
Amneal PharmaceuticalsRytary$15
1 payment
  • Meals for Rytary · 2019-08-26 · $15
Supernus PharmaceuticalsTrokendi Xr$13
1 payment
  • Meals for Trokendi Xr · 2019-09-21 · $13

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Novartis Pharmaceuticals Corporation · A Single-Arm, Prospective, Multicentre, Open-Label Study To Evaluate Ofatumumab Treatment Effectiveness and Patient Reported Outcomes in Patients With Relapsing Multiple Sclerosis Transitioning From Dimethyl Fumarate Or Fingolimod Therapy · 2021Their institution$59,743
Novartis Pharmaceuticals Corporation · A Single-Arm, Prospective, Multicentre, Open-Label Study To Evaluate Ofatumumab Treatment Effectiveness and Patient Reported Outcomes in Patients With Relapsing Multiple Sclerosis Transitioning From Dimethyl Fumarate Or Fingolimod Therapy · 2022Their institution$52,901
Novartis Pharmaceuticals Corporation · A Single-Arm, Prospective, Multicentre, Open-Label Study To Evaluate Ofatumumab Treatment Effectiveness and Patient Reported Outcomes in Patients With Relapsing Multiple Sclerosis Transitioning From Dimethyl Fumarate Or Fingolimod Therapy · 2023Their institution$1,500
Novartis Pharmaceuticals Corporation · A Single-Arm, Prospective, Multicentre, Open-Label Study To Evaluate Ofatumumab Treatment Effectiveness and Patient Reported Outcomes in Patients With Relapsing Multiple Sclerosis Transitioning From Dimethyl Fumarate Or Fingolimod Therapy · 2020Their institution$228

Professional record

NPI
1265618995
Licence
CA A113308California A113308: Current · expires 2028-03-31
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Neurology (2084N0400X); Federal specialty code 2084N0600X (2084N0600X)
Mailing address
325 Distel Cir, Los Altos, CA, 94022
NPI first listed
2008-01-11
NPI last updated
2020-05-29
NPI record certified
2020-05-29

This is when the NPI record was last certified, not a medical board exam.